US Stock MarketDetailed Quotes

EIGRQ Eiger BioPharmaceuticals

Watchlist

8.500
0.0000.00%

15min DelayClose Sep 27 16:00 ET

12.59MMarket Cap-0.72P/E (TTM)

Eiger BioPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Eiger BioPharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2023/Q4	3.803M / 6.479M	--
--	2023/Q3	3.209M / 4.911M	--
--	2023/Q2	4.643M / 4.569M	--
--	2023/Q1	4.118M / 3.822M	--
--	2022/Q4	2.696M / 4.422M	--

DatePeriodRevenue/EstimateEarnings Call

--2023/Q43.803M / 6.479M--

--2023/Q33.209M / 4.911M--

--2023/Q24.643M / 4.569M--

--2023/Q14.118M / 3.822M--

--2022/Q42.696M / 4.422M--

Unlock Free Earnings Estimates

Open Account

Eiger BioPharmaceuticals Earnings Reports

Eiger BioPharmaceuticals | 10-K/A: Annual report (Amendment)

Apr 29, 2024 16:49 ET

Eiger BioPharmaceuticals | 10-K: FY2023 Annual Report

Apr 8, 2024 17:23 ET

Eiger BioPharmaceuticals | 10-Q: Q3 2023 Earnings Report

Nov 9, 2023 16:27 ET

Eiger BioPharmaceuticals | 8-K: Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 9, 2023 16:14 ET